相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum Laminin γ2 Monomer as a Diagnostic and Predictive Biomarker for Hepatocellular Carcinoma
Taro Yamashita et al.
HEPATOLOGY (2021)
Risk factors and molecular characterization of penile cancer: impact on prognosis and potential targets for systemic therapy
Anita Thomas et al.
CURRENT OPINION IN UROLOGY (2020)
NH2-terminal fragment of ZF21 protein suppresses tumor invasion via inhibiting the interaction of ZF21 with FAK
Makoto Nagano et al.
CANCER SCIENCE (2020)
Unique Biological Activity and Potential Role of Monomeric Laminin-2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review
Hiroshi Yasuda et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
PI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?
Maria Luisa Gasparri et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2017)
The nature and biology of basement membranes
Ambra Pozzi et al.
MATRIX BIOLOGY (2017)
Serum monomeric laminin-2 as a novel biomarker for hepatocellular carcinoma
Hirofumi Kiyokawa et al.
CANCER SCIENCE (2017)
Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma
Masayuki Kamada et al.
CANCER SCIENCE (2015)
LAMC2 enhances the metastatic potential of lung adenocarcinoma
Y. W. Moon et al.
CELL DEATH AND DIFFERENTIATION (2015)
Extracellular matrix determinants and the regulation of cancer cell invasion stratagems
A. L. Willis et al.
JOURNAL OF MICROSCOPY (2013)
Fibroblast Growth Factor 2 Induces E-Cadherin Down-Regulation via PI3K/Akt/mTOR and MAPK/ERK Signaling in Ovarian Cancer Cells
Man-Tat Lau et al.
PLOS ONE (2013)
Laminins in basement membrane assembly
Erhard Hohenester et al.
CELL ADHESION & MIGRATION (2013)
The ERBB network: at last, cancer therapy meets systems biology
Yosef Yarden et al.
NATURE REVIEWS CANCER (2012)
Membrane Type 1-Matrix Metalloproteinase Cleaves Off the NH2-Terminal Portion of Heparin-Binding Epidermal Growth Factor and Converts It into a Heparin-Independent Growth Factor
Naohiko Koshikawa et al.
CANCER RESEARCH (2010)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Developmental and Pathogenic Mechanisms of Basement Membrane Assembly
Peter D. Yurchenco et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Defining the role of laminin-332 in carcinoma
Cherise M. Guess et al.
MATRIX BIOLOGY (2009)
Development of a new tracking tool for the human monomeric laminin-γ2 chain in vitro and in vivo
Naohiko Koshikawa et al.
CANCER RESEARCH (2008)
CA125 in ovarian cancer
Nathalie Scholler et al.
BIOMARKERS IN MEDICINE (2007)
Gain of 1q25-32, 12q23-24.3, and 17q 12-22 facilitates tumorigenesis and progression of human squamous cell lung cancer
J. Ma et al.
JOURNAL OF PATHOLOGY (2006)
Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy
S Miyamoto et al.
CANCER SCIENCE (2006)
Laminin-5 (laminin-332): Unique biological activity and role in tumor growth and invasion
K Miyazaki
CANCER SCIENCE (2006)
A simplified laminin nomenclature
M Aumailley et al.
MATRIX BIOLOGY (2005)
ERBB receptors and cancer: The complexity of targeted inhibitors
NE Hynes et al.
NATURE REVIEWS CANCER (2005)
Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin γ2 chain
N Koshikawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH
K Hashimoto et al.
MODERN PATHOLOGY (2004)
Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution
S Schenk et al.
JOURNAL OF CELL BIOLOGY (2003)
Strategies for MMP inhibition in cancer:: Innovations for the post-trial era
CM Overall et al.
NATURE REVIEWS CANCER (2002)
Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5
N Koshikawa et al.
JOURNAL OF CELL BIOLOGY (2000)
分享论文
